The Securities and Exchange Commission has delayed approval for prediction markets ETFs, bringing up memories of the long battle over bitcoin funds.
Levi Strauss exceeded Wall Street's Q2 expectations for both earnings and revenue, prompting the company to raise its full-year guidance for adjusted EPS and sales. The denim maker also increased its dividend.
SpaceX's stock closed below its IPO price for the second consecutive day, trading at $148. Despite inclusion in the Nasdaq 100 and mostly bullish analyst ratings, some analysts recommend selling shares, citing valuation concerns.
Despite new GLP-1 drugs and Medicare coverage, most employers aren't covering them for weight loss due to high costs. Many are exploring alternative support methods for employees.
Federal Reserve officials showed divergent views on interest rates at their June meeting, with some anticipating easing conditions allowing for lower rates and others expecting elevated inflation necessitating hikes. The committee ultimately voted to maintain the current rate range.
Oil prices surged to $74/barrel for WTI and $78 for Brent after President Trump declared the Iran ceasefire agreement over. Treasury yields rose as inflation worries grew, impacting cyclical stocks negatively. AI stocks, particularly Nvidia, rebounded on news of potential chip sales to China, though past reports have not materialized.
Rivian announced plans to raise capital by selling ~75 million shares, surprising investors and causing the stock to drop. The author argues this is a necessary move for manufacturing and believes the dilution is minor, presenting a potential buying opportunity.
